<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" type="text/css" href="css/style-manual.css">
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
    <script src="js/script.js"></script>
</head>
<body>
<!--Lumilast-------------------------------------------------------->
<div class="bodyDiv" id="idLumilast">
    <div class="w3-container w3-center w3-animate-left">
        <h2 class="mango">Lumilast</h2>
    </div>
<b>Product Orientation & Presentation:</b><br>
<table class="table1">
<tr>
    <td><b>Brand Name:</b><br>
	Lumilast
	</td>
</tr>

<tr>
    <td><b>Generic & Strength:</b><br>
	Roflumilast INN 0.3% Cream.
	</td>
</tr>
  
 <tr>
     <td><b>
	Dosage Form:</b><br>
	30 gm Cream.
	 </td>
</tr>
	 
<tr>
    <td><b>Therapeutic Class:</b><br>
	Anti-psoriasis
	</td>
</tr>
 
<tr>
    <td><b>Sub Therapeutic class:</b><br>
	--
	</td>
</tr>
		 
<tr>
    <td><b>Commercial Pack:</b><br>
	30gm
	</td>
</tr>
	 
<tr>
    <td><b>Price (TP):</b><br>
	250.00 Bdt/ Tube.
    </td>
</tr>	
	 
<tr>
    <td><b>Flavour:</b><br>
	--
	</td>
</tr>
  
<tr>
    <td><b>Indication:</b><br>
	Topical treatment of plaque psoriasis,
including intertriginous areas, in pateients12 years of age and older.

	</td>
</tr>
  
<tr>
    <td><b>Pregnancy:</b><br>
	--
    </td>
</tr>

<tr>
    <td><b>Lactation:</b><br>
	--
    </td>
</tr>

<tr>
    <td><b>Children:</b><br>
	--
    </td>
</tr>
  
<tr>
    <td><b>Brand Name Justification:</b><br>
	--
	</td>
</tr>

<tr>
    <td><b>Brand Slogan:</b><br>
	-- 
    </td>
</tr>

<tr>
    <td><b>Dosage & Administration:</b><br>
&#x2022; To be applied on the

affected areas once daily.
    </td>
</tr>

<tr>
    <td><b>Key Selling Points:</b><br>
&#x2022; More effective in plaque psoriasis than topical steroids.<br>
&#x2022; Significantly improves psoriasis in sensitive area.<br>
&#x2022; Simplifies the treatment regimen of psoriasis.
    </td>
</tr>

<tr>
    <td><b>Target Doctor:</b><br>
&#x2022; Dermatologists
<br>
&#x2022; Medicine specialists
<br>
&#x2022; GPs

    </td>
</tr>

<tr>
    <td><b>Side effects:</b><br>
&#x2022; 
    </td>
</tr>

<tr>
    <td colspan="4">
    	<table class="table2">
<thead>
    <tr>
       <th>
       </th>
       <th>Mode of action:
       </th>
       <th>
       </th>
    </tr>
</thead>

<tbody>
    <tr>
       <td>
	   </td>
       <td>Lumilast/Roflumilast
	   </td>
	  <td>
	  </td>
    </tr>
    <tr>
       <td>
	   </td>
       <td><b>&#8681;</b>
	   </td>
	   <td>
	   </td>
    </tr>
    <tr>
       <td>
	   </td>
       <td>inhibits Phosphodiesterase-4 (PDE-4) enzyme.
	   </td>
	   <td>
	   </td>
    </tr>
	
	<tr>
       <td>
	   </td>
       <td><b>&#8681;</b>
	   </td>
	   <td>
	   </td>
    </tr>
    
    <tr>
       <td>
	   </td>
       <td>increases intracellular concentrations of cAMP.
	   </td>
	   <td>
	   </td>
    </tr>
   
   <tr>
       <td><b>&#8681;</b>
	   </td>
       <td>
	   </td>
	   <td><b>&#8681;</b>
	   </td>
    </tr>
    
    <tr>
       <td>decreases the production of proinflammatory cytokines

such as tumor necrosis factor (TNF-&#945;), interferon (IFN-&#947;), IL-2

	   </td>
       <td>
	   </td>
	   <td>increases anti-inflammatory mediators

such as interleukin-10 (IL-10)

	   </td>
    </tr>
    
    <tr>
       <td>
	   </td>
       <td><b>&#8681;</b>
	   </td>
	   <td>
	   </td>
    </tr>
    
    <tr>
       <td>
	   </td>
       <td>clearance of signs & symptoms of psoriasis.
	   </td>
	   <td>
	   </td>
    </tr>
</tbody>
</table>
 </td>
</tr>
</table>
<br><br>
Adenosine monophosphate is a second messenger, or cellular signal occurring within cells, that is important in many biological processes. cAMP is a derivative of adenosine triphosphate (ATP) and used for intracellular signal transduction in many different organisms, conveying the cAMP-dependent pathway.



<br><br>
<b>Model Detailing Talk</b><br>
Sir/Madam, পরিশেষে আমরা আপনাকে advance একটা good news দিতে চাই।<br>
	
Sir / Madam, with all respect to you, আপনার কাছে কি মনে হয়? যদি
Psoriasis এর এমন কোনো simple but highly effective treatment
regimen পাওয়া যায়, যেটা once daily, non-steroidal এবং skin এর
sensitive area তে ব্যবহার করা যায় without any limitation? কেমন হবে
product টা? আমাদের দৃঢ় বিশ্বাস, নিশ্চয়ই এটা Plaque psoriatic patients দের
জন্য একটা blessing হবে!<br>
	
আপনি জেনে খুবই আনন্দিত হবেন, আমরা Navana Pharma থেকে খুব শিঘ্রই
Plaque Psoriasis এর management-এ একটি দারুন cream, first time in
Bangladesh, introduce করতে যাচ্ছি, যেটি non-steroidal, কিন্তু steroid
থেকেও better. শুধু তাই নয়, product টির performance existing সকল ক্রীম
থেকে বেস্ট এবং আশা করছি, খুব শিঘ্রই Plaque psoriatic patient দের জন্য খুব
ভালো একটা treatment অপশন সবার আগে আপনার হাতে তুলে দিতে পারবো।
<br><br>
স্যার, আপনাকে last visit/গত একটি visit এ advanced একটা good news নিয়েছিলাম যে, আমরা Psoriasis এর জন্য steroid থেকে এমনকি অন্যান্য conventional topical option থেকে best & safe একটা product মার্কেটেআনতে যাচ্ছি। আমরা সেটা নিয়ে এসেছি।<br>
	
আজ আমি সবার আগে আপনাকে সেই চমৎকার product টি সম্পর্কে বলবো, যেটা হতে পারে সোরিয়াসিস পেশেন্টদের জন্য একটা novel treatment option to live better without steroids. Plaque psoriasis এর চিকিৎসায় বহুদিন ধরে ব্যবহার হওয়া steroids বা এর বিভিন্ন combination সমূহে বেশ কিছু পার্শ্ব-প্রতিক্রিয়া রয়েছে। এছাড়াও, একজন এক্সপার্ট হিসেবে আপনি জানেন, steroid-গুলোর long term এবং sensitive
area তে ব্যবহারেও অনেক limitations আছে।<br>
	
Plaque psoriasis patient দের জন্য একটা better treatment option offer করতে,
আমরা নাভানা ফার্মা থেকে first time in Bangladesh নিয়ে এসেছি, Lumilast 30g Cream Lumilast হচ্ছে FDA approved Roflumilast 0.3% এর একটি topical cream preparation that offers "Steroid-free plaque psoriasis treatment".<br>
	
শুরুতেই Lumilast এর মেকানিজমটা যদি একটু বলি, Lumilast PDE 4(phosphodiesterase-4) enzyme কে inhibit করার মাধ্যমে pro-inflammatory mediators (TNF-a, IFN-y & IL-2) এর production কমায় এবং anti-inflammatory mediators (IL-10) এর production বাড়ায় । এই dual mode of action-এর ফলে
psoriasis এর signs এবং symptoms effectively clear হয়।‌ <br>
FDA verified study তে দেখা গিয়েছে, Lumilast, I mean, Roflumilast cream ব্যবহারের ফলে 08 weeks-এ‌ 42% patients almost clear skin achieve করে, যেখানে বহু প্রচলিত Betamethasone + Calciprotirene-এ 29%-37% patients response পায়। এমনকি Lumilast এর result অন্যান্যconventional topical even highly expensive Tapinarof cream থেকে better.<br>
So, It provides a reliable treatment.<br>
	
স্যার, আগেই উল্লেখ করেছি, potent steroidal ক্রীমগুলো sensitive skin area তে recommended না, সেখানে ‌Lumilast highly recommended & excellent performance show করে। Lumilast ব্যবহারে 08 weeks-এ 75% patients এর sensitive area'র psoriasis এর remarkably improvement হয় এবং এর মধ্যে
60% patients এর totally clear skin achieve করে।<br>
	
এছাড়াও, Lumilast এর itch reduction (চুলকানি কমানো) performance commonly used product থেকে better Study তে পাওয়া গেছে, Lumilast মাত্র 08 weeks 69% patients এর significant itch reduction‌ করে, যা অন্যান্য ক্রীমে এমনকি Steroid এও পাওয়া যায় না।<br>
So, Lumilast brings better relief for patients.<br>
	
Psoriasis এর management-এ excellent efficacy ছাড়াও যদি আরো কিছু essential para menters যেমনঃ<br>
Sensitive/intertriginous area তে ব্যবহার,<br>
Age coverage ( 12 yrs+),<br>
Lack of warnings & precautions, <br>
Safety on long term use নিয়ে study করে দেখা গেছে, একমাত্র Lumilast ই সব কয়টি criteria একমাত্র fulfil করতে পারে। <br>
So, it can be your drug of choice. Lumilast এর systemic absorption খুব সামান্য হওয়াতে এর adverse effect steroids থেকে অনেক কম।<br>
	
আরেকটি তথ্য, Lumilast এর recommended dose once daily, যা রোগীর জন্য সুবিধাজনক।<br>
	
Finally, Lumilast...<br>
• More effective in plaque psoriasis than topical steroids.<br>
• Significantly improves psoriasis in sensitive area.<br>
Simplifies the treatment regimen of psoriasis.<br>
Considering the excellent efficacy & safety, আপনাকে অনুরোধ করবো আপনার কাছে আসা সোরিয়াসিস এর
পেশেন্টদের কে Lumilast prescribe করার জন্য।<br>
Thank you for your time.<br><br>


Short Detailing <br>
Sir/Madam,<br>
স্যার, এমন একটা Drug হলে কেমন হয়, যেটি Plaque psoriasis এর একটি non-steroidal treatment, কিন্তু steroids থেকেও ভালো efficacy show
করে? নিশ্চয়ই সোরিয়াসিস পেশেন্টদের জন্য blessing হবে! Plaque psoriatic patient দের জন্য একটা better treatment option offer করতে, আমরা
নাভানা ফার্মা থেকে first time in Bangladesh নিয়ে এসেছি, Lumilast 30g Cream. Lumilast হচ্ছে FDA approved Roflumilast 0.3% এর একটি
once daily topical cream preparation that offers "Steroid-free plaque psoriasis treatment".<br>

FDA verified study face, Lumilast, I mean, Roflumilast cream
08 weeks-4 42% patients almost clear skin
achieve-Betamethasone + Calciprotirene-4 29% -37% patients response*
আপনি জানেন, যেখানে potent steroidal ক্রীমগুলো body'র sensitive skin area তে recommended না, সেখানে Lumilast ব্যবহারে 08 weeks-এ
75% patients sensitive area's psoriasis remarkably improvement 60% patients totally clear skin
achieve করে।

Study তে পাওয়া গেছে, Lumilast ব্যবহারে মাত্র 08 weeks-এ 69% patients এর significant itch reduction হয়, যা অন্যান্য ক্রীমে এমনকি steroid
এণ্ড পাওয়া যায় না। Lumilast এর adverse effect ও steroids থেকে অনেক কম এবং long-term ব্যবহারে safe. আপনাকে অনুরোধ করবো আপনার কাছে আসা সোরিয়াসিস এর পেশেন্টদের কে Lumilast prescribe করার জন্য।<br>
Thank you for your time, Sir.<br><br>


Frequently Asked questions:<br><br>
<b>01. What is plaque psoriasis? What are the symptoms of plaque psoriasis?</b><br>
Ans: Plaque psoriasis (psoriasis vulgaris) is a long-lasting (chronic) autoimmune disease that causes skin cells to reproduce very quickly. It causes thick, scaly patches called plaques on skin. The symptoms of plaque psoriasis include:<br>
• Itchy skin<br>
• Cracked, dry skin<br>
• Skin pain.<br>
• Redness of the skin<br><br>

<b>02. What are the major limitations of topical steroid preparations in the management of plaque psoriasis?</b><br>
Ans: The major limitations of topical steroid preparations in the management of plaque psoriasis are:<br>
• Skin thinning<br>
• Skin pigmentation<br>
• Stretch marks on the skin<br>
• Redness<br>
• Not suitable for long-term use<br>
• Not recommended to use below 18 years of age<br>
• Not recommended to use in the sensitive areas of the body  (e.g. Under-arm, Under the breasts, Groin, stomach folds etc.)<br><br>

<b>03. Why did you introduce Lumilast?</b><br>
	
Ans: Psoriasis requires a long-term management but all the existing treatment options have potential drawbacks such as-<br>
• Steroids (e.g. Betamethasone) cause skin thinning, pigmentation, stretch marks & redness.<br>
• Vitamin-D analogues (e.g. Calcipotriene) cause sub-optimal response & local irritation.<br>
• Topical calcineurin inhibitors (e.g. Tacrolimus) are not approved & have risk of cancer.<br>
• Most of the options are not even suitable & speciﬁcally tested for psoriasis at sensitive (intertriginous) areas.<br>

To help the patient of plaque psoriasis to live better, we, Navana Pharma, introduced Lumilast, which is a non-steroidal, once daily treatment. You will be happy to let you know that, Lumilast oﬀers highest eﬃcacy to improve plaque psoriasis.<br><br>

<b>04. I prescribe topical steroids & observing satisfactory result. Why should I prescribe Lumilast?</b><br>
	
Ans: Thank you, Sir for your query.<br> As you know, topical steroids has so many adverse eﬀects & limitations of use. More-
over, these are contraindicated for intertriginous area (sensitive area) & long term use as well. To manage plaque psoriasis, you can conﬁdently prescribe Lumilast instead of steroid because -<br>

• Lumilast oﬀers almost clear skin in 42% of patients within 08 weeks whereas the potent steroidal combination may clear up to 37%(Betamethasone + Calciprotirene 29% -37%)<br>
• Lumilast improves signs and symptoms of psoriasis in intertriginous areas (sensitive areas) up to 75% within 08 weeks whereas topical steroids are contraindicated.<br>

So, considering better eﬃcacy & safety, I strongly recommend you to prescribe Lumilast for plaque psoriatic patients.<br><br>

<b>05. What is intertriginous area?</b><br>
	
Ans: An intertriginous area is where two skin areas may touch or rub together. Examples of intertriginous areas are under-arm, groin, skin folds of the breasts etc. It is also called sensitive areas of the body because skin layer is thin in these areas compared to the other parts of the body.<br><br>

<b>06. How is Lumilast the best option available in the market?</b><br>
Ans: Sir, Lumilast simpliﬁes the treatment regimen of psoriasis. Lumilast is the only drug available in the market which can serves all the following requirements:<br><br>
	
<table class="table3">
  <thead>
    <tr>
      <th scope="col" colspan="1">
      	</th>
      <th>
"Betamethasone +

Calcipotriene
"	</th>	<th>	"Halobetasol +

Tazarotene
"	</th>	<th>	Tapinarof	</th>	<th>	"Roflumilast
"	</tr>
  </thead>
  <tbody>
<tr>	<td>	Intertriginous symptom improvement	</td>	<td>	×	</td>	<td>	×	</td>	<td>	✓	</td>	<td>	✓	</tr>
<tr>	<td>	Approved from 12 years	</td>	<td>	×	</td>	<td>	×	</td>	<td>	×	</td>	<td>	✓	</tr>
<tr>	<td>	Significant itch reduction	</td>	<td>	✓	</td>	<td>	×	</td>	<td>	×	</td>	<td>	✓	</tr>
<tr>	<td>	Limited warnings and precautions	</td>	<td>	×	</td>	<td>	×	</td>	<td>	✓	</td>	<td>	✓	</tr>
<tr>	<td>	No limitation on duration of use	</td>	<td>	×	</td>	<td>	✓	</td>	<td>	✓	</td>	<td>	✓	</tr>
</tbody>
</table>

Note:  *× = Not studied or not approved or not indicated

*✓, = Approved with treatmentsuccess
<br><br>

<b>07. Does Lumilast reduce itching?</b><br>
Ans: Yes sir, Lumilast shows signiﬁcant itch reduction from week two.<br>
At week 08, 69% of patients achieved WI-NRS ≥ 4 point improvement by using Lumilast,<br>
whereas 66% of patients achieved WI-NRS ≥ 4 point improvement by using Betamethasone & Calcipotriene combination.<br><br>

<b>08. What is the meaning of WI-NRS?</b><br>
	
Ans: The full form of WI-NRS is Worst Itch Numeric Rating Scale. It’s a scale to assess the itching intensity of the patient.<br><br>

<b>09. What is the price of Lumilast?</b><br>
Ans: Thank you sir for your interest on Lumilast. The price of Lumilast is only 250 Tk./30g Tube. Other steroidal and
non-steroidal treatment costs from 380-1500 Tk./Tube. Lumilast is very cost-eﬀective for psoriatic patients to continue their long term treatment.<br><br>

<b>10. I prescribe Tapinarof, which is also a non-steroidal, recently FDA approved drug. Why should I prescribe Lumilast?</b><br>
	
Ans: Thank you, Sir for your interest on Lumilast. As per studies, Lumilast oﬀers almost clear skin in 42% of patients
within 08 weeks whereas tapinarof may clear up to 31%. Tapinarof cannot be given from 12 years of age. Moreover, the
price of Tapinarof is very high which is not cost eﬀective for plaque psoriatic patients to continue their long-term treatment.<br>
So, considering all these beneﬁts, I strongly recommend you to prescribe Lumilast for plaque psoriasis patient.<br><br>

<b>11. What are the key beneﬁts of Lumilast?</b><br>
	
Ans: The key beneﬁts of Lumilast are:<br>
• Non-steroidal treatment of plaque psoriasis better than steroids.<br>
• Once daily treatment.<br>
• It’s a cream preparation which is not greasy, oily like ointment, ensures patient compliance.<br>
• Signiﬁcantly improves psoriasis in intertriginous (sensitive) areas of the body.<br>
• Approved from 12 years of age.<br>
• Signiﬁcant itch reduction compared to topical steroids.<br>
• Very minimal warnings & precaution compared to topical steroids.<br>
• Cost eﬀective treatment.<br>
• No limitation on duration of use.
</div>   
<footer>
    <p>© 2024 Md. Nurullah. All rights reserved.</p>
</footer>
<center><div class="ovalEnd">The End-Lumilast</div></center><!--End Line---->
</body>
</html>